RT Book, Section
A1 Panus, Peter C.
A1 Jobst, Erin E.
A1 Masters, Susan B.
A1 Katzung, Bertram
A1 Tinsley, Suzanne L.
A1 Trevor, Anthony J.
SR Print(0)
ID 6091765
T1 Chapter 13. Sedative-Hypnotic Drugs
T2 Pharmacology for the Physical Therapist
YR 2009
FD 2009
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-146043-9
LK accessphysiotherapy.mhmedical.com/content.aspx?aid=6091765
RD 2024/04/23
AB Assignment  of  a  drug  to  the  sedative-hypnotic  class  indicates  that  its  major  therapeutic  use  is  to  cause  sedation  (with  concomitant  relief  of  anxiety)  or  to  encourage  sleep.  Because  there  is  considerable  chemical  variation  within  this  group,  this  drug  classification  is  based  on  clinical  uses  rather  than  on  similarities  in  chemical  structure.  Anxiety  states  and  sleep  disorders  are  common  problems,  and  sedative-hypnotics  are  widely  prescribed  drugs  worldwide.  Drugs  in  this  class  include  alcohols,  benzodiazepines,  barbiturates,  carbamates,  and  several  newer  hypnotics,  including  eszopiclone,  zaleplon,  and  zolpidem  (Figure  13–1).